On September 18, the Department of Health and Human Services (HHS) introduced new initiatives designed to enhance the diagnosis and therapeutics associated with long COVID. These initiatives came in the wake of a roundtable discourse involving patients and healthcare experts. The series of actions linked to these initiatives is poised to advance research on the subject and deliver improved patient care.
One notable action includes the establishment of an online platform to foster knowledge sharing among physicians, researchers, and healthcare systems. This is geared towards exchanging crucial clinical insights on the diagnosis and treatment procedures for long COVID. The HHS is also launching a nationwide campaign aimed at raising awareness about long COVID and its associated symptoms.
Simultaneously, a new report detailing health insurance utilization among adults afflicted with long COVID was released by the Agency for Healthcare Research. The intricacies of defining long COVID remain challenging, with no standard definition in existence. Experts assert that this lack of a precise definition has imposed impediments towards the progression of research and identification of effective treatments for patients.
This comes amid announcements of significant donations towards education expansion in the medical sector, with Florida State University receiving a $10 million donation to bolster its nurse education program.